Gilead Sciences, Inc. (GILD) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of…
Source: Yahoo Finance
Sector & Industry
Gilead Sciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NASDAQ exchange.
Gilead Sciences, Inc. at a Glance
| Company | Gilead Sciences, Inc. |
| Ticker | GILD |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $151.00 |
| Market cap | $187.23B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.66 |
| 52-week high | $157.29 |
| 52-week low | $108.46 |
| Dividend yield | 2.17% |
| Ex-dividend date | 15 Sep 2026 |
| Beta | 0.35 |
| Return on equity (ROE) | -20.68% |
| Debt-to-equity | 223.47% |
| Average volume | 7.09M |
| Shares outstanding | 1.24B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 17,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Gilead Sciences, Inc.'s current P/E ratio?
- Gilead Sciences, Inc. (GILD) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Gilead Sciences, Inc.'s market capitalisation?
- Gilead Sciences, Inc.'s market cap is $187.23B based on our latest snapshot. See how it ranks by market cap →
- What is GILD's 52-week range?
- Over the past 52 weeks, GILD has traded between $108.46 and $157.29. What does the 52-week range mean? →
- How volatile is Gilead Sciences, Inc. compared to the market?
- Gilead Sciences, Inc. has a beta of 0.35, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Gilead Sciences, Inc. pay a dividend?
- Gilead Sciences, Inc.'s trailing annual dividend yield is 2.17%. Compare with other high-yield stocks →
- What exchange is GILD listed on?
- GILD is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Gilead Sciences, Inc. in?
- Gilead Sciences, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →